Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer…
Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
Recover your password.
A password will be e-mailed to you.